The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Open accessAbstract
BACKGROUND.: Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a rare but challenging group of malignant neoplasms and occur at virtually any site of the GEP system. In 2006, a new TNM classification system was proposed for the staging and grading of upper GEP NETs. METHODS.: The prognostic relevance of the TNM classification system was analyzed retrospectively in 202 patients from a referral center with histologically proven foregut NET. Patients were classified according to previous classification systems and the TNM classification. Survival data were acquired and statistical analyses were performed by using log‐rank and Cox regression testing. RESULTS.: Primary tumors were gastric (n = 48), duodenal (n = 23), and pancreatic (n = 131). During the observation period, 21% of patients died. The overall 5‐ and 10‐year survival rates were 75% and 64%, respectively. Previous classification systems discriminated between low‐grade and high‐grade malignant NETs but did not allow further prognostic differentiation. In contrast, the proposed TNM classification was able to differentiate significantly between different tumor stages (stages I‐III vs stage IV; P < .01) and cellular proliferation rates according to Ki‐67 labeling (grade 1 vs grade 2, P = .04; grade 1 vs grade 3 and grade 2 vs grade 3, P < .01). Cox regression analysis confirmed an increased risk of reduced survival for patients with stage III or IV NET and grade 2 or 3 NET. CONCLUSIONS.: The current results demonstrated the prognostic relevance of the newly proposed TNM classification system for foregut NETs with statistical significance for the subgroups of both the staging classification and the grading system. Thus, the new classification system provides a valid and powerful tool for prognostic stratification of GEP NETs in clinical practice and research. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationRamage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
THE CLASSIFICATION OF CARCINOID TUMOURS
WILLIAMS, E. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90951-6 · Cited by 885
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Kulke, M. H., & Mayer, R. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401107 · Cited by 741
Revised classification of neuroendocrine tumours of the lung, pancreas and gut
Capella, C., Heitz, P. U., H�fler, H., Solcia, E., & Kl�ppel, G. (1995) · Virchows Archiv · doi:10.1007/bf00199342 · Cited by 553
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
Self-citationGuidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477
Self-citationWeber, H. C., Venzon, D. J., Lin, J.-T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., Norton, J. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90124-8 · Cited by 467
Hochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.030 · Cited by 397
Panzuto, F., Nasoni, S., Falconi, M., Corleto, V. D., Capurso, G., Cassetta, S., Di Fonzo, M., Tornatore, V., Milione, M., Angeletti, S., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01017 · Cited by 391
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Pape, U.-F., Berndt, U., Muller-Nordhorn, J., Bohmig, M., Roll, S., Koch, M., Willich, S. N., & Wiedenmann, B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0017 · Cited by 384
Self-citationRindi, G., Azzoni, C., Rosa, S. L., Klersy, C., Paolotti, D., Rappel, S., Stolte, M., Capella, C., Bordi, C., & Solcia, E. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70174-5 · Cited by 354
Self-citationGuidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
Ramage, J. K., Davies, A. H. G., Ardill, J., Bax, N., Caplin, M., Grossman, A., Hawkins, R., McNicol, A. M., Reed, N., Sutton, R., et al. (2005) · Gut · doi:10.1136/gut.2004.053314 · Cited by 350
Arnold, R., Trautmann, M. E., Creutzfeldt, W., Benning, R., Benning, M., Neuhaus, C., Jürgensen, R., Stein, K., Schäfer, H., Bruns, C., et al. (1996) · Gut · doi:10.1136/gut.38.3.430 · Cited by 342
Yu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., & Jensen, R. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.615 · Cited by 341
Population-Based Study of Islet Cell Carcinoma
Yao, J. C., Eisner, M. P., Leary, C., Dagohoy, C., Phan, A., Rashid, A., Hassan, M., & Evans, D. B. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9566-6 · Cited by 338
Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
de Herder, W. W., Niederle, B., Scoazec, J.-Y., Pauwels, S., Klöppel, G., Falconi, M., Kwekkeboom, D. J., Öberg, K., Eriksson, B., Wiedenmann, B., et al. (2006) · Neuroendocrinology · doi:10.1159/000098010 · Cited by 295
Self-citationGastrinoma (Duodenal and Pancreatic)
Jensen, R. T., Niederle, B., Mitry, E., Ramage, J. K., Steinmüller, T., Lewington, V., Scarpa, A., Sundin, A., Perren, A., Gross, D., et al. (2006) · Neuroendocrinology · doi:10.1159/000098009 · Cited by 284
Pelosi, G., Bresaola, E., Bogina, G., Pasini, F., Rodella, S., Castelli, P., Iacono, C., Serio, G., & Zamboni, G. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90303-2 · Cited by 267
Epidemiology and survival in patients with carcinoid disease in the Netherlands
Quaedvlieg, P. F. H. J., Visser, O., Lamers, C. B. H. W., Janssen-Heijen, M. L. G., & Taal, B. G. (2001) · Annals of Oncology · doi:10.1023/a:1012272314550 · Cited by 260
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
Falconi, M., Plöckinger, U., Kwekkeboom, D. J., Manfredi, R., Körner, M., Kvols, L., Pape, U. F., Ricke, J., Goretzki, P. E., Wildi, S., et al. (2006) · Neuroendocrinology · doi:10.1159/000098012 · Cited by 257
Self-citationKölby, L., Persson, G., Franzén, S., & Ahrén, B. (2003) · British Journal of Surgery · doi:10.1002/bjs.4149 · Cited by 222
A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?
Modlin, I. M., Lye, K. D., & Kidd, M. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04027.x · Cited by 217
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
Ducreux, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02003-7 · Cited by 196
Frank, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00146-x · Cited by 191
Revised Classification of Neuroendocrine Tumors of the Lung, Pancreas and Gut
Capella, C., Heitz, P. U., Höfler, H., Solcia, E., & Klöppel, G. (1994) · Digestion · doi:10.1159/000201197 · Cited by 186
The future of the TNM staging system in colorectal cancer: time for a debate?
Quirke, P., Williams, G. T., Ectors, N., Ensari, A., Piard, F., & Nagtegaal, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70205-x · Cited by 173
Well-Differentiated Gastric Tumors/Carcinomas
Ruszniewski, P. B., Fave, G. D., Cadiot, G., Komminoth, P., Chung, D. C., Kos‐Kudła, B., Kianmanesh, R., Hochhauser, D., Arnold, R., Ahlman, H., et al. (2006) · Neuroendocrinology · doi:10.1159/000098007 · Cited by 153
Self-citationWiedenmann, B., Jensen, R. T., Mignon, M., Modlin, C. I., Skogseid, B. M., Doherty, G. M., & Öberg, K. (1998) · World Journal of Surgery · doi:10.1007/s002689900387 · Cited by 148
Self-citationGastrointestinal Carcinoids: Characterization by Site of Origin and Hormone Production
Onaitis, M. W., Kirshbom, P. M., Hayward, T. Z., Quayle, F. J., Feldman, J. M., Seigler, H. F., & Tyler, D. S. (2000) · Annals of Surgery · doi:10.1097/00000658-200010000-00010 · Cited by 142
Pape, U., Böhmig, M., Berndt, U., Tiling, N., Wiedenmann, B., & Plöckinger, U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.025 · Cited by 137
Self-citationRare Functioning Pancreatic Endocrine Tumors
O’Toole, D., Salazar, R., Falconi, M., Kaltsas, G., Couvelard, A., de Herder, W. W., Hyrdel, R., Nikou, G. C., Krenning, E. P., Vullierme, M., et al. (2006) · Neuroendocrinology · doi:10.1159/000098011 · Cited by 136
Anlauf, M., Perren, A. A., Meyer, C. L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.058 · Cited by 133
Carcinoid tumors of the duodenum
Mullen, J. T., Wang, H., Yao, J. C., Lee, J. H., Perrier, N. D., Pisters, P. W. T., Lee, J. E., & Evans, D. B. (2005) · Surgery · doi:10.1016/j.surg.2005.09.016 · Cited by 125
Öberg, K. (2004) · Acta Oncologica · doi:10.1080/02841860410018502 · Cited by 120
Endocrine tumours of the stomach
Fave, G. D., Capurso, G., Milione, M., & Panzuto, F. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.05.002 · Cited by 110
Members of Nordic Ne Tumour Group:, Öberg, K., Astrup, L. B., Eriksson, B. K., Falkmer, S. E., Falkmer, S., Gustafsen, J., Haglund, C., Knigge, U., Vatn, M. H., et al. (2004) · Acta Oncologica · doi:10.1080/02841860410018575 · Cited by 105
Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974–97
Levi, F., Te, V.-C., Randimbison, L., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1394 · Cited by 90
Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)
Jensen, R. T., Rindi, G., Arnold, R., Lopes, J. M., Brandi, M. L., Bechstein, W. O., Christ, E., Taal, B. G., Knigge, U., Ahlman, H., et al. (2006) · Neuroendocrinology · doi:10.1159/000098008 · Cited by 82
Self-citationCarcinoids of unknown origin: Comparative analysis with foregut, midgut, and hindgut carcinoids
Kirshbom, P. M., Kherani, A. R., Onaitis, M. W., Feldman, J. M., & Tyler, D. S. (1998) · Surgery · doi:10.1067/msy.1998.93105 · Cited by 73
Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system
Wiedenmann, B., John, M., Ahnert‐Hilger, G., & Riecken, E. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050261 · Cited by 66
Self-citationFave, G. D., Marignani, M., Corleto, V. D., Angeletti, S., D’Ambra, G., Ferraro, G., D’Adda, T., Azzoni, C., Jensen, R. T., Annibale, B., et al. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80147-5 · Cited by 19
Low Nuclear Proliferative Activity Is Associated With Nonmetastatic Islet Cell Tumors
Jordà, M., Ghorab, Z., Fernández, G. L., et al. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-196-lnpaia · Cited by 17
Pape, U.-F., & Wiedenmann, B. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.002 · Cited by 14
Self-citation
Cited by
Klimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Self-citationJensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Metadata
- Authors
- Pape, U., Jann, H., Müller‐Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., Koch, M., Röcken, C., Rindi, G., & Wiedenmann, B.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-07-08
- Volume
- 113
- Issue
- 2
- Pages
- 256-265
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2066768964
- Cited by
- 405
- References
- 48
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.